New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Addex Therapeutics Ltd
ADXN
Shape
US Flag

NASDAQ

15M

Biotechnology

Next Earning date - 11 Nov 2024

15M

Biotechnology

Next Earning date - 11 Nov 2024

10.26USD
Shape0.01Ā ( 0.10%)
favorite-chart

Relative Strenght

16
favorite-chart

Volume Buzz

-96%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

63%

Quote Panel

Shape
Updated October 14, 2024
1W -0.77 % 1M 1.58 % 3M 23.32 % 1Y 28.25 %

Key Metrics

Shape
  • Market Cap

    15.46M


  • Shares Outstanding

    1.47M


  • Share in Float

    1.47M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    10.26


  • Average Volume

    286482


  • Beta

    1.978


  • Range

    5.0-27.9


  • Industry

    Biotechnology


  • Website

    https://www.addextherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

11.03x

P/E Ratio

15.92x

P/S Ratio

67.73x

P/B Ratio

0.0

Debt/Equity

519.3%

Net Margin

$-19.7

EPS

How ADXN compares to sector?

P/E Ratio

Relative Strength

Shape

ADXN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$745K

Shape546%

2025-Revenue

$7.13

Shape-5581%

2025-EPS

$745K

Shape43%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-11.20
vsĀ -14.40

Q4.22

arrow
arrow

N/A

-5.00
vsĀ -16.60

Q1.23

arrow
arrow

N/A

NA
vsĀ NA

Q2.23

arrow
arrow

N/A

-5.00
vsĀ -23.60

Q3.23

arrow
arrow

N/A

-4.07
vsĀ -11.20

Q4.23

arrow
arrow

N/A

NA
vsĀ -5.00

Q1.24

arrow
arrow

N/A

5
vsĀ NA

Q2.24

arrow
arrow

N/A

NA
vsĀ -5.00

Q3.24

arrow
arrow

N/A

-1.21
vsĀ -4.07

Q4.24

arrow
arrow

N/A

-1.21
vsĀ NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-40%

409.4KĀ  vsĀ 682K

Q4.22

arrow
arrow

+49%

592.4KĀ  vsĀ 397.5K

Q1.23

arrow
arrow

+111%

500.9KĀ  vsĀ 237.2K

Q2.23

arrow
arrow

+244%

630.9KĀ  vsĀ 183.4K

Q3.23

arrow
arrow

-20%

327.7KĀ  vsĀ 409.4K

Q4.23

arrow
arrow

-74%

153.5KĀ  vsĀ 592.4K

Q1.24

arrow
arrow

-53%

234.9KĀ  vsĀ 500.9K

Q2.24

arrow
arrow

-82%

115.3KĀ  vsĀ 630.9K

Q3.24

arrow
arrow

-38%

202.4KĀ  vsĀ 327.7K

Q4.24

arrow
arrow

+31%

201.6KĀ  vsĀ 153.5K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-52%

-0.52
vsĀ -1.05

Q4.22

arrow
arrow

-74%

-0.74
vsĀ -0.52

Q1.23

arrow
arrow

-59%

-0.59
vsĀ -0.74

Q2.23

arrow
arrow

-44%

-0.44
vsĀ -0.59

Q3.23

arrow
arrow

-66%

-0.66
vsĀ -0.44

Q4.23

arrow
arrow

-249%

-2.49
vsĀ -0.66

Q1.24

arrow
arrow

+224%

2.24
vsĀ -2.49

Q2.24

arrow
arrow

+102%

1.02
vsĀ 2.24

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

5

5
vsĀ 4

25%

Q1.22

arrow
arrow

5

5
vsĀ 5

NA

Q2.22

arrow
arrow

5

5
vsĀ 5

NA

Q3.22

arrow
arrow

9

9
vsĀ 5

80%

Q4.22

arrow
arrow

7

7
vsĀ 9

-22%

Q1.23

arrow
arrow

7

7
vsĀ 7

NA

Q2.23

arrow
arrow

3

3
vsĀ 7

-57%

Q3.23

arrow
arrow

5

5
vsĀ 3

67%

Earnings Growth

Latest News